FDA adds warning to Ozempic label about risk for blocked intestines
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Ozempic, a type 2 diabetes drug that has increasingly been used to help with weight loss, will now be labeled as having the potential to block intestines.
Sep 28, 2023
0
5
Coronaviruses are a global public health risk, with three highly infectious species, including SARS-CoV-2, emerging in the last 20 years. New research by the University of Bristol has shown how an HIV drug could stop many ...
Dec 5, 2023
0
59
Several new genes associated with conditions such as Attention-deficit hyperactivity disorder (ADHD) have been identified, unearthing a significant connection between these disorders and our immune system that could lead ...
Oct 31, 2023
0
76
Phosphodiesterase type 5 inhibitors (PDE5i)—an erectile dysfunction drug sold under the names Viagra, Levitra, Cialis, and others—are a common medical treatment for erectile dysfunction (ED) in men with cardiovascular ...
Jan 15, 2024
0
22
The United States has a proven treatment to reduce HIV infection risk by up to 99%. The health system just needs to get better at offering it. In 2021, the country had over 36,000 new HIV diagnoses, yet PrEP (HIV pre-exposure ...
Sep 26, 2023
0
19
A new study by researchers at the Case Western Reserve School of Medicine reveals that a chemical used in the diabetes drug Ozempic and the weight-management drug Wegovy is not associated with an increased risk for suicidal ...
Jan 5, 2024
0
17
A small molecule previously shown to enhance strength in injured or old laboratory mice does so by restoring lost connections between nerves and muscle fibers, Stanford Medicine researchers have found.
Oct 12, 2023
0
96
Dutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatments. As a result, previously tested drugs may incorrectly appear to be ineffective or only minimally effective. ...
Jan 9, 2024
2
100
A new approach to treating neuropathic pain is making a key step forward thanks to researchers at The University of Texas at Austin.
Jan 30, 2024
0
74
The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorized by the UK's medicines regulation authority for use in weight loss and weight management. The decision was made on ...
Nov 15, 2023
0
0